Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Janssen Pharmaceutical to Provide Update on Fulranumab Clinical DevelopmentBy: SMi Group “It's an excellent forum for networking and discussion” – OGBConsulting The programme will examine key areas such as assessing new mechanisms from bench to bedside, enhancing the translation of animal data into pain patients, advances in opioids, neuropathic pain, plus much more. Conference highlights include an exclusive keynote address from Janssen Pharmaceutical Medical Leader, Dr Kathleen Kelly. Dr Kelly will be presenting attendees with Phase 2 efficacy and safety data for Fulranumab and will also be discussing nerve growth factors with a focus on antibody inhibitors, injury and inflammation. This event will aim to: Discuss and evaluate the latest new therapeutic mechanisms from bench to bedside with key insight from Merck, Spinifiex, Eli Lilly, AbbVie and UCB Deliver key presentations from Mundipharma, Nektar and Morpheus Pharmaceuticals on advances to opioids and strategies to reduce abuse potential Explore the latest in the area of Neuropathic pain for 2014 with the latest case studies from Neuroscience Technologies and GW Pharmaceuticals Evaluate the translation gap with case studies from a pre-clinical and clinical perspective from Karolinska Institutet and OGB Consulting The 14th annual Pain Therapeutics email will also feature two interactive post conference workshops taking place on Wednesday 21st May 2014 at the Holiday Inn Regents Park Hotel, London: How Can Success in Analgesia be Improved (http://www.smi- Workshop Leaders: Steve Harrison, Vice President, Research Biology, Nektar Pharmaceuticals Birgit Priest, Research Advisor, Eli Lilly Opportunities for Collaborative Pain Projects (http://www.smi- Workshop Leader: Fiona Boissonade, Head of Neuroscience, University of Sheffield For further information on the programme, speaker line-up or to register, visit http://www.smi- PAIN THERAPEUTICS 19TH – 20TH MAY 2014 HOLIDAY INN REGENTS PARK HOTEL, LONDON UK http://www.smi- About SMi Group Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries. More information can be found at www.smi-online.co.uk End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|